Karsten Lunze, MD, MPH, DrPH, FACPM, FAAP Hear my name
Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
General Internal Medicine

MD, Humboldt-Universität zu Berlin
DPH/DrPH, Boston University School of Public Health
DM, Humboldt-Universität zu Berlin
MPH, Harvard School of Public Health

Pronouns: he/him/his



Karsten Lunze holds a medical degree and doctorates in genetic epidemiology and public health. Following clinical training in pediatrics at Charité Berlin, Germany, and the Johns Hopkins Children's Center, Baltimore, MD, and in public health/preventive medicine and addiction medicine at BMC, he has conducted research concerned with individual and structural risks affecting disadvantaged populations. His clinical health services research has been devoted to improving the health of women and newborns in resource-limited environments. Karsten's federally and foundation-supported global health research aims to improve access to quality care for disadvantaged populations worldwide by addressing intersectional stigma and other barriers to prevention and care via multi-level behavioral and pharmacological interventions for people with addictions, HIV, TB and other conditions.

Director of Global Health, Section of General Internal Medicine, Department of Medicine, Boston Medical Center
Co-Director, Providence/Boston Center for AIDS Research (CFAR) Substance Use Research Core

Access to quality care for disadvantaged people
Stigma, HIV prevention and care in key populations
Behavioral interventions in humanitarian settings
Implementation Science
Global maternal and newborn health

Diversity, Equity, Inclusion and Accessibility

Increasing diversity, equity, inclusion, and accessibility in our work and workforce is central to my lab’s shared vision of equal access to quality prevention and care for everyone. Our mission is to empower disadvantaged people worldwide and assist them in coping with stigma and other barriers to accessing care. Inherently, in our work and our lives, we therefore share the core values of tolerance and inclusion as the opposite of stigma and discrimination. As first-generation immigrant to our university’s country, I welcome and celebrate diversity as a natural enrichment of our research activities and of our learning. We take great satisfaction from our achievements that strengthened the evidence-base around behavioral interventions for disadvantaged people, made possible by winning over people from around the world, with a fascinating spectrum of backgrounds, to gather and work with us. Realizing that tolerance and inclusion are continuously and ubiquitously under attack, we want to provide workplaces that are safe spaces. Aware of our perspectives, biased and position of privilege, we aspire to build a sense of belonging for everyone who shares BMC’s motto of excellent care, without exception.

I strive to foster learner-centered mentoring and teaching of diverse students, fellows and early-stage faculty, including underrepresented individuals. Our structural approach to increasing equity and accessibility is community engagement, i.e., partnering for all aspects of our research and teaching with people who have lived experiences. My research and teaching focuses on social and other determinants of population health, and underrepresented scholars have been instrumental in trailblazing our stigma intervention work. We created our Clinical Undergraduate Research in Addictions - Training and Experiences (CURATE) and Physician Research in Training (PRiT) programs [ https://www.bumc.bu.edu/care/education-and-training-programs/training-programs/mssrp/ ] that I lead with the firm goal of increasing diversity, equity, inclusion, and accessibility in research and teaching – this will make our mission even more divertido.

Faculty
Boston University Chobanian & Avedisian School of Medicine
Medicine
Clinical Addiction Research and Education Unit




Pre notification Estimating Mediation and Moderation Effects in HIV Care Continuum Intervention Trials for People who Use Drugs
04/01/2023 - 01/31/2028 (PI)
San Diego State University Research Foundation National Institute o

Preventing Mental Disorders Among Women Internally Displaced by War in Ukraine: The SHAWL Trial
08/16/2023 - 08/15/2026 (PI)
National Institute of Mental Health/NIH/DHHS
1R34MH134077-01

Substance Use Prevention for Recently displaced Adults (SUPRA)
04/01/2024 - 03/31/2026 (PI)
National Institute on Drug Abuse/NIH/DHHS
1R61DA059856-01

2024 (INVEST) Drug Use and Addiction Research Fellowship
01/23/2023 - 01/22/2025 (PI)
National Institute on Drug Abuse/NIH/DHHS

Sustaining recovery for people on opioid agonist treatment with conversational agents
09/30/2023 - 09/29/2024 (PI)
National Institute on Drug Abuse/NIH/DHHS
1R34DA058124-01A1

Community-engaged implementation strategies for acceptance interventions to improve access to care for people with HIV and injection drug use
09/01/2023 - 08/31/2024 (PI)
National Institute on Drug Abuse/NIH/DHHS
1R03DA059341-01

Providence/Boston Center for AIDS Research (CFAR): CORE SUPPORT (Cores A,B,H,K,L)
07/01/2023 - 06/30/2024 (PI)
The Miriam Hospital National Institute o

Competitive Revision to Stigma, Risk Behaviors and Health Care Among HIV-Infected Russian People Who Inject Drugs
09/01/2020 - 08/31/2023 (PI)
National Institute on Drug Abuse/NIH/DHHS
3R00DA041245-05S1

Stigma, Risk Behaviors and Health Care among HIV-Infected Russian People Who…
09/01/2018 - 08/31/2023 (PI)
National Institute on Drug Abuse/NIH/DHHS
5R00DA041245-05

Providence Boston Center for AIDS Research (CFAR)
07/01/2018 - 06/30/2023 (PI)
The Miriam Hospital National Institute o
5P30AI042853-24

Showing 10 of 13 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs
2024 Substance Use Prevention for Recently displaced Adults (SUPRA) 1R61DA059856-01
2023 Sustaining recovery for people on opioid agonist treatment with conversational agents 1R34DA058124-01A1
2023 Community-engaged implementation strategies for acceptance interventions to improve access to care for people with HIV and injection drug use 1R03DA059341-01
2023 Preventing Mental Disorders Among Women Internally Displaced by War in Ukraine: The SHAWL Trial 1R34MH134077-01
2023 Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention" 5R01AA030460-02
2022 Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention" 1R01AA030460-01
2022 Core K - Substance Use Research Core 5P30AI042853-24-7400
2021 Core K - Substance Use Research Core 5P30AI042853-23-7400 905
2020 Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs 3R00DA041245-05S1
2020 Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs 5R00DA041245-05
Showing 10 of 15 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Davis A, Knudsen HK, Walker DM, Chassler D, Lunze K, Westgate PM, Oga E, Rodriguez S, Tan S, Holloway J, Walsh SL, Oser CB, Lefebvre RC, Fanucchi LC, Glasgow L, McAlearney AS, Surratt HL, Konstan MW, Huang TT, LeBaron P, Nakayima J, Stein MD, Rudorf M, Nouvong M, Kinnard EN, El-Bassel N, Tilley J, Macoubray A, Savitzky C, Farmer A, Beers D, Salsberry P, Huerta TR. Effects of the Communities that Heal (CTH) intervention on perceived opioid-related community stigma in the HEALing Communities Study: results of a multi-site, community-level, cluster-randomized trial. Lancet Reg Health Am. 2024 Apr; 32:100710.View Related Profiles. PMID: 38510790; PMCID: PMC10950860; DOI: 10.1016/j.lana.2024.100710;
     
  2. Rosen S, Blokhina E, Truong V, Bereznicka A, Gnatienko N, Quinn E, Lioznov D, Krupitsky E, Michals A, Lunze K, Samet JH. Comparative costs and potential affordability of a multifaceted intervention to improve treatment outcomes among people with HIV who inject drugs in Russia: economic evaluation of the LINC-II randomized controlled trial. J Int AIDS Soc. 2024 Feb; 27(2):e26208.View Related Profiles. PMID: 38403887; PMCID: PMC10895073; DOI: 10.1002/jia2.26208;
     
  3. Kimmel SD, Samet JH, Cheng DM, Vetrova M, Idrisov B, Rossi SL, Rateau L, Astone K, Michals A, Sisson E, Blokhina E, Milet-Carty N, Bovell-Ammon BJ, Gnatienko N, Truong V, Krupitsky E, Lunze K. Stigma and other correlates of sharing injection equipment among people with HIV in St. Petersburg, Russia. Glob Public Health. 2024 Jan; 19(1):2296009.View Related Profiles. PMID: 38158724; PMCID: PMC10764055; DOI: 10.1080/17441692.2023.2296009;
     
  4. Chatterjee A, Baker T, Rudorf M, Walt G, Stotz C, Martin A, Kinnard EN, McAlearney AS, Bosak J, Medley B, Pinkhover A, Taylor JL, Samet JH, Lunze K. Mobile treatment for opioid use disorder: Implementation of community-based, same-day medication access interventions. J Subst Use Addict Treat. 2024 Apr; 159:209272.View Related Profiles. PMID: 38128649; PMCID: PMC10947870; DOI: 10.1016/j.josat.2023.209272;
     
  5. Canfield J, Truong V, Bereznicka A, Bridden C, Liebschutz J, Alford DP, Saitz R, Samet JH, Walley AY, Lunze K. Evaluation of a student clinical research education program in addiction medicine. Ann Med. 2023 Dec; 55(1):361-370.View Related Profiles. PMID: 36629696; PMCID: PMC9848279; DOI: 10.1080/07853890.2022.2154833;
     
  6. Bosak J, Drainoni ML, Christopher M, Medley B, Rodriguez S, Bell S, Kim E, Stotz C, Hamilton G, Bigsby C, Gillen F, Kimball J, McClay C, Powers K, Walt G, Battaglia T, Chassler D, Sprague Martinez L, Lunze K. Community advisory board members' perspectives on their contributions to a large multistate cluster RCT: a mixed methods study. J Clin Transl Sci. 2024; 8(1):e1.View Related Profiles. PMID: 38384918; PMCID: PMC10879854; DOI: 10.1017/cts.2023.673;
     
  7. Davis A, Stringer KL, Drainoni ML, Oser CB, Knudsen HK, Aldrich A, Surratt HL, Walker DM, Gilbert L, Downey DL, Gardner SD, Tan S, Lines LM, Vandergrift N, Mack N, Holloway J, Lunze K, McAlearney AS, Huerta TR, Goddard-Eckrich DA, El-Bassel N. Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study. Int J Drug Policy. 2023 Dec; 122:104241.View Related Profiles. PMID: 37890391; PMCID: PMC10841835; DOI: 10.1016/j.drugpo.2023.104241;
     
  8. Raj A, Gnatienko N, Cheng DM, Blokhina E, Dey AK, Wagman JA, Toussova O, Truong V, Rateau L, Lunze K, Krupitsky E, Samet JH. Provider-patient experiences and HIV care utilization among people living with HIV who inject drugs in St. Petersburg, Russia. Int J Qual Health Care. 2023 Oct 05; 35(4).View Related Profiles. PMID: 37642351; PMCID: PMC10558037; DOI: 10.1093/intqhc/mzad068;
     
  9. Samet JH, Blokhina E, Cheng DM, Rosen S, Lioznov D, Lunze K, Truong V, Gnatienko N, Quinn E, Bushara N, Raj A, Krupitsky E. Rapid access to antiretroviral therapy, receipt of naltrexone, and strengths-based case management versus standard of care for HIV viral load suppression in people with HIV who inject drugs in Russia (LINC-II): an open-label, randomised controlled trial. Lancet HIV. 2023 Sep; 10(9):e578-e587.View Related Profiles. PMID: 37659841; PMCID: PMC10653654; DOI: 10.1016/S2352-3018(23)00143-1;
     
  10. Chen S, Walt G, Aldrich A, McAlearney AS, Linas B, Amuchi B, Freedman DA, Goddard-Eckrich D, Gibson E, Hartman Ms J, Bosak J, Lunze K, Jones L, Christopher M, Salsberry P, Jackson R, Back S, Drainoni ML, Walker DM. A Qualitative Study of Health Equity's Role in Community Coalition Development. Health Educ Behav. 2023 Jun 28; 10901981231179755.View Related Profiles. PMID: 37376998
     
Showing 10 of 88 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 87 publications over 18 distinct years, with a maximum of 13 publications in 2022

YearPublications
20041
20061
20092
20102
20112
20122
20137
20143
20157
20164
201712
20182
20193
20206
20216
202213
202312
20242

2018 American Association of Public Health Physicians: Presidential Citation
2017 American Public Health Association: Sidel Levy Award for Peace
2016 American College of Preventive Medicine: Humanism in Medicine Award
2016 National Institute on Alcohol Abuse and Alcoholism (NIAAA): NIH New Investigator Award
2015 UNHCR/EMERCOM : UN Humanitarian Medal
2013 NIDA and Taiwan CDC; Taipei, Taiwan: Early Career Investigator Award for Global Health
2013 ISAM, Kuala Lumpur, Malaysia: NIDA-ISAM Award
2012 American College of Preventive Medicine: Don Gemson Resident Award
2012 NIH: NIDA Women & Sex/Gender Junior Investigator Travel Award
2012 The International Society for the Study of Drug Policy, Canterbury, UK: Prize for Best Study Influencing Drug Policy
2012 American Society of Addiction Medicine: Ruth Fox Award
2007-2008 Harvard University: Holtzer Award
2005 German Hypertension Society, Heidelberg, Germany : Young Investigator Award

We welcome interested and dedicated students, postdocs and clinical fellows to learn about and contribute to our portfolio in HIV prevention and maternal & newborn health research.

Learn more about our Medical Student Summer Research Program (MSSRP) here https://www.bumc.bu.edu/care/education-and-training-programs/training-programs/mssrp/ and see contacts below if you are interested.

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Co-Mentor or Peer Mentor
  • Diversity Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')
  • Assistant
         Name: Ve Truong, Jules Canfield
         Email: ve.truong@bmc.org; Jules.Canfield@bmc.org

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Lunze's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department